The benefit of SGLT2i therapy beyond improved glycaemic control was first reported in the EMPA-REG study which reported a reduced incidence of major adverse cardiovascular events in patients with type 2 diabetes [19]
Sadhu A, Upadhyay P, Agrawal A, Ilango K, Karmakar D, Singh GPI, et al
Compounded or research-grade combinations of cagrilintide and semaglutide require separate reconstitution and potentially separate injections, adding complexity
New Advances in the Pharmacological Treatment of Obesity in the Context of Bariatric Surgery Pharmaceutical development has advanced toward dual and triple agonists targeting GLP-1, GIP, glucagon, and amylin pathways to amplify metabolic benefits
Alli Orlistat is a prescription FDA-approved drug for obesity management
Consequently, these cells undergo excessive lipid peroxidation and ultimately succumb to ferroptosis